cleveland.com: Jonathan Stamler, professor at the School of Medicine, discussed his team’s discovery that could potentially provide a new target to treat diabetes: an enzyme that regulates the effects of nitric oxide on insulin receptors.
cleveland.com: Jonathan Stamler, professor at the School of Medicine, discussed his team’s discovery that could potentially provide a new target to treat diabetes: an enzyme that regulates the effects of nitric oxide on insulin receptors.
